Parkinson's DiseaseA Hidden Clue in the Gut May Signal Parkinson’s DiseaseApril 22, 2026Alzheimer DiseaseA Positive Outlook May Lower Dementia RiskApril 16, 2026Alzheimer DiseaseAlzheimer’s Risk Isn’t the End of the Story — It’s the BeginningApril 11, 2026Parkinson's DiseaseFrankly Speaking: The Emotional Side of Parkinson’sApril 3, 2026Parkinson's DiseaseA Father-Daughter Conversation on Parkinson’s: Inside Frankly SpeakingApril 3, 2026Alzheimer DiseaseMyth or Fact: Debunking Common Hearing Health MisconceptionsApril 2, 2026Alzheimer DiseaseMeat Intake May Benefit Some at Higher Dementia RiskApril 1, 2026Spinal Muscular AtrophyFDA Approves New High-Dose Nusinersen for SMA March 30, 2026Alzheimer DiseaseStudy Finds Link Between Severe Infections and DementiaMarch 29, 2026Alzheimer DiseaseType 1 Diabetes May Carry Higher Dementia RiskMarch 27, 2026Multiple SclerosisBecause I Can: A Story of Strength With MSMarch 25, 2026Parkinson's DiseaseThe Incisionless Brain Procedure Giving Patients With Essential Tremor Their Lives BackMarch 20, 2026Alzheimer DiseaseBlood Pressure Clues May Help Predict Dementia RiskMarch 20, 2026Alzheimer DiseaseHearing Health Tips for World Hearing Day, With Briana Scuderi, Au.D.March 3, 2026Myasthenia GravisLiving Fully Again After Myasthenia GravisFebruary 28, 2026Multiple SclerosisLiving With MS Without Putting Life on Hold February 17, 2026Neurofibromatosis Type 1 (NF1)FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1February 12, 2026Multiple SclerosisThe Educated Patient Podcast: Father and Son Discuss Progress, Hope and Life With Multiple SclerosisFebruary 10, 2026Alzheimer DiseaseHow Minimally Processed Red Meat May Support Healthy AgingJanuary 27, 2026Parkinson's DiseaseA Comforting Broccoli Cheese Soup That Supports Everyday WellnessJanuary 19, 2026
Parkinson's DiseaseA Father-Daughter Conversation on Parkinson’s: Inside Frankly SpeakingApril 3, 2026
Parkinson's DiseaseThe Incisionless Brain Procedure Giving Patients With Essential Tremor Their Lives BackMarch 20, 2026
Neurofibromatosis Type 1 (NF1)FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type 1February 12, 2026
Multiple SclerosisThe Educated Patient Podcast: Father and Son Discuss Progress, Hope and Life With Multiple SclerosisFebruary 10, 2026
